Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

-Kathryn Osann Researcher Activity Profile

Research Author Detailed Information 

profile photo of Kathryn OsannKathryn osann researcher

Kathryn Osann Publication Rate By Year

Kathryn Osann has published 2 paper(s) in 2006, 8 paper(s) in 2007, 10 paper(s) in 2008, for a total of 20 research publications in total.

Kathryn K Osann Author Information

LAST NAME: osann

FIRST NAME: Kathryn

INITIALS: k

AFFILIATION:

Papers

Kathryn Osann's Publication Record

  1. In vivo imaging of oral mucositis in an animal model using optical coherence tomography and optical Doppler tomography. Year Published: 2007
  2. Beckman Laser Institute, University of California at Irvine, CA 92612, USA. pwsmith@uci.edu
  3. Microvascular blood flow dynamics associated with photodynamic therapy, pulsed dye laser irradiation and combined regimens. Year Published: 2006
  4. Beckman Laser Institute, University of California, Irvine, California 92612, USA.
  5. Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. Year Published: 2007
  6. Division of Basic and Clinical Immunology, University of California, Irvine, CA 92697, USA. aagrawal@uci.edu
  7. Influence of the gynecologic oncologist on the survival of ovarian cancer patients. Year Published: 2007
  8. Division of Gynecologic Oncology, Department of Obstetrics, University of California, San Francisco School of Medicine, San Francisco Comprehensive Cancer Center, San Francisco, California 94143-1702, USA. chanjohn@obgyn.ucsf.edu
  9. Adjuvant radiotherapy in incompletely staged IC and II endometrioid uterine cancer. Year Published: 2007
  10. Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, California 94143-1702, USA.
  11. Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancer. Year Published: 2007
  12. Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, UCSF Comprehensive Cancer Center, 94143-1702, USA. chanjohn@obgyn.ucsf.edu
  13. Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States. Year Published: 2008
  14. Division of Gynecologic Oncology, Department of Obsetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, UCSF Comprehensive Cancer Center, San Francisco, California.
  15. Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancer. Year Published: 2007
  16. Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, UCSF Comprehensive Cancer Center, 94143-1702, USA. chanjohn@obgyn.ucsf.edu
  17. Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer. Year Published: 2008
  18. Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Services, University of California, San Francisco School of Medicine, Helen Diller Family Comprehensive Cancer Center, 94143-1702, USA. chanjohn@obgyn.ucsf.edu
  19. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Year Published: 2008
  20. Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, UCSF, School of Medicine and Comprehensive Cancer Center, San Francisco, CA 94143-1702, USA.
  21. Adjuvant radiotherapy in incompletely staged IC and II endometrioid uterine cancer. Year Published: 2007
  22. Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, California 94143-1702, USA.
  23. Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer. Year Published: 2008
  24. Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Services, University of California, San Francisco School of Medicine, Helen Diller Family Comprehensive Cancer Center, 94143-1702, USA. chanjohn@obgyn.ucsf.edu
  25. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Year Published: 2008
  26. Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, UCSF, School of Medicine and Comprehensive Cancer Center, San Francisco, CA 94143-1702, USA.
  27. TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases. Year Published: 2008
  28. Department of Pediatrics, Division of Human Genetics, University of California, Irvine, California 92697, USA.
  29. TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases. Year Published: 2008
  30. Department of Pediatrics, Division of Human Genetics, University of California, Irvine, California 92697, USA.
  31. Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer. Year Published: 2008
  32. Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Services, University of California, San Francisco School of Medicine, Helen Diller Family Comprehensive Cancer Center, 94143-1702, USA. chanjohn@obgyn.ucsf.edu
  33. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Year Published: 2008
  34. Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, UCSF, School of Medicine and Comprehensive Cancer Center, San Francisco, CA 94143-1702, USA.
  35. Analysis of phase II studies on targeted agents and subsequent phase III trials: what are the predictors for success? Year Published: 2008
  36. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143-1702, USA. chanjohn@obgyn.ucsf.edu
  37. Head circumference and height in autism: a study by the Collaborative Program of Excellence in Autism. Year Published: 2006
  38. Department of Psychiatry, The Brain Institute at the University of Utah, Salt Lake City, Utah 84108, USA. janet.lainhart@hsc.utah.edu
  39. Fluorescence diagnostics of Helicobacter pylori-infected human gastric mucosa: establishing technique and validity. Year Published: 2007
  40. Beckman Laser Institute, University of California, Irvine, USA.
 

Molecular Station USER Menu

Welcome to Molecular Station!

You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

Already registered? Login now below.

User Name:

Password:

Already registered and Forgot your password? Click below to recover it.

Recover Lost Password

Join now - it's fast and free!

Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

Research Terms of Usage and Disclaimer
Home
Features

Protocols

DNA Forum

Science Forum

DNA Forum
Biology Forum

Science News


[CaRP] XML error: Invalid document end at line 2

For more click here:Science News